Assembly Biosciences (ASMB) Assets (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Assets of $235.5 million for Q1 2026, up 137.85% year-over-year from $99.0 million in Q1 2025, and down 8.57% quarter-over-quarter from $257.6 million in Q4 2025.
Assembly Biosciences (ASMB) Assets (2010 - 2026) Analysis & Trends
Assembly Biosciences' Assets history runs 17 years deep, the most recent figure standing at $235.5 million for Q1 2026.
- In Q1 2026, Assets rose 137.85% year-over-year to $235.5 million; the TTM figure through Mar 2026 stood at $235.5 million (up 137.85% YoY), while the FY2025 annual figure was $257.6 million, up 116.16% from the prior year.
- Assets for Q1 2026 stood at $235.5 million, down from $257.6 million in the prior quarter.
- The five-year high for Assets was $257.6 million in Q4 2025, with the low at $51.6 million in Q3 2023.
- The 5-year median for Assets is $119.2 million (2024), against an average of $131.5 million.
- The sharpest annual moves came in 2023 and 2025: Assets plunged 57.51% in 2023, then surged 139.37% in 2025.
- Assembly Biosciences' Assets stood at $101.8 million in 2022, then surged by 34.41% to $136.8 million in 2023, then retreated by 12.9% to $119.2 million in 2024, then surged by 116.16% to $257.6 million in 2025, then fell by 8.57% to $235.5 million in 2026.
- Business Quant data shows ASMB's Assets at $235.5 million in Q1 2026, $257.6 million in Q4 2025, and $240.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | 330.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 330.83 Mn |
| Mar 31, 2026 | 235.51 Mn |
| Dec 31, 2025 | 257.59 Mn |
| Sep 30, 2025 | 240.00 Mn |
| Jun 30, 2025 | 80.78 Mn |
| Mar 31, 2025 | 99.02 Mn |
| Dec 31, 2024 | 119.17 Mn |
| Sep 30, 2024 | 100.26 Mn |
| Jun 30, 2024 | 115.32 Mn |
| Mar 31, 2024 | 119.88 Mn |
| Dec 31, 2023 | 136.82 Mn |
| Sep 30, 2023 | 51.63 Mn |
| Jun 30, 2023 | 66.58 Mn |
| Mar 31, 2023 | 83.12 Mn |
| Dec 31, 2022 | 101.79 Mn |
| Sep 30, 2022 | 121.52 Mn |
| Jun 30, 2022 | 143.45 Mn |
| Mar 31, 2022 | 162.73 Mn |
| Dec 31, 2021 | 191.06 Mn |
| Sep 30, 2021 | 248.97 Mn |